Background/Aims: The prevalence of Helicobacter pylori (H. pylori) infection has been reported to be lower in individuals with inflammatory bowel disease (IBD) in some Western countries. We investigated H. pylori infection in Korean patients with IBD and any possible associations of H. pylori infection with drug therapy for IBD and the phenotype of Crohn's disease (CD). Methods: We studied 316 unselected patients with IBD, including 169 ulcerative colitis (UC) patients and 147 with CD, and the control group consisted of 316 age-and gender-matched healthy people who received a comprehensive medical examination for a regular checkup purpose. Infection rates of H. pylori as detected by the urea breath test were compared between the IBD patients and the controls. Results: A statistically significant difference in H. pylori infection rate was noticed between the IBD patients (25.3%) and the controls (52.5%; p＜0.001), and between UC (32.0%) and CD patients (17.7%; p=0.04). Among the IBD patients, the age group of ＜60 and individuals with a history of taking metronidazole (13.0%; p=0.038) or ciprofloxacin (6.7%; p=0.001) were found to have a meaningfully lower infection rate, but those who did not take antibiotics still showed H. pylori infection rate significantly lower than the controls (CD 22.0% vs. UC 33.8% vs. Control 52.5%, p＜0.001). With an exception of age, phenotypic characteristics showed no significant relations with H. pylori infection rate in CD patients. Conclusions: Korean patients with IBD, particularly CD, were found to have a significantly lower H. pylori infection rate than the controls. This association was more evident in those ＜60 years old, which suggested that H. pylori infection might be deemed to lower possible risks of IBD in younger adults. (Korean J Gastroenterol 2009;53:341-347)
Introduction
The prevalence of Helicobacter pylori (H. pylori) infection in patients with inflammatory bowel disease (IBD) is considered to be lower than that in the general population. [1] [2] [3] [4] [5] However, the reason for this lower prevalence of H. pylori infection in IBD patients is largely unknown although many potential causative factors, i.e. a history of previous antibiotic therapy, and the long term use of medications like sulfasalazine, have been investigated. 1, 3, [5] [6] [7] It is interesting that published epidemiologic data shows that environmental factors, such as age and country of origin, are significantly related to the prevalence of IBD and H. pylori infection. [8] [9] [10] [11] H. pylori infection was found to show an age-related increase in prevalence, compared to bimodal distribution pattern for age at onset in IBD. 8, 11 Over the past decades, the prevalence of IBD has steadily increased in some countries while the incidence of H. pylori and other similar infectious agents has declined. 8, 10, 12 Furthermore, the prevalence of H. pylori infection varies from country to country, and is higher in Asia than in developed Western countries. However, IBD is relatively uncommon in Asian countries, but far more prevalent in developed Western countries. 8, 10 Like other Asian countries, Korea has a high prevalence of H. pylori infection, and a low prevalence of IBD, 12, 13 and interestingly, the prevalence of H. pylori in Korea has fallen while that of IBD has increased, which suggests that environmental changes associated with socioeconomic development and particularly industrialization may have modified respective disease risks. once a patient had been assigned B3, then he/she was regarded as B3 for the remainder of the disease course. 17 Patients who had recently received proton pump inhibitors, antibiotics and/or bismuth compounds were excluded.
Statistical analysis
The data were recorded and calculations were performed using SPSS statistical software (Statistical Package for the Social Sciences, version 13.0). Prevalences were compared with using chi-square statistics. Associations between H. pylori status, and treatment for IBD and the CD phenotype were determined using the chi-square test. Two tailed values for significance were used in all statistical tests, and significance was accepted at the p＜0.05 level.
Results

Patient characteristics
The mean age of the IBD patients was 40.1 (range Drugs other than antibiotics were found to have no influence on H. pylori infection rate among IBD patients (Table 3 ).
The prevalence of H. pylori infection in CD patients as defined by the Vienna classification
When the cases were classified according to age at diagnosis, 9, 10, 19, 20 and it has been proposed that IBD development may also be influenced by environmental factors, such as domestic hygiene, mode of feeding, and perinatal infections. [21] [22] [23] [24] Thus, the lower prevalence of H. pylori infections in patients with IBD might be due to better hygiene and sanitation during childhood and adolescence, and this may have predisposed them to IBD. This proposition is consistent with the findings of previous studies which indicated that improved hygiene might increase the risk of IBD. 24, 25 As has been previously mentioned for allergic and autoimmune disease, the "hygiene hypothesis" 
